4basebio PLC (4BB.L) LSE

Currency In GBp

AD

Valuation

Market Cap95.37M
Enterprise Value94.07M
P/E Ratio-4.59
PEG Ratio0.36
Price/Sales Ratio45.73
Price/Book Ratio7.68
Enterprise/Revenue44.97
Enterprise/EBITDA-5.02

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-9.99
Operating Margin-9.88
AD

Management Effectiveness

Return On Assets-0.57
Return On Equity-1.16

Income Statement

Revenue1.69M
Revenue/Share0.11
Gross Profit548,000
EBITDA-15.58M
Net Income-16.91M
Diluted EPS-1.09

Balance Sheet

Total Cash17.8M
Total Cash/Share1.15
Total Debt16.5M
Total Debt/Equity1.63
Current Ratio7.31
Book Value Per Share0.65

Price History

52-Week Change-49.24
52-Week High1,040
52-Week Low420
Moving Average 50 Days499.83
Moving Average 200 Days608.01

Statistics

Average Volume1,758
Shares Outstanding15.48M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD